354 related articles for article (PubMed ID: 16552236)
1. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV
Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
[TBL] [Abstract][Full Text] [Related]
2. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeted therapy of head and neck cancer: review and clinical development challenges.
Le Tourneau C; Faivre S; Siu LL
Eur J Cancer; 2007 Nov; 43(17):2457-66. PubMed ID: 17904355
[TBL] [Abstract][Full Text] [Related]
4. Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.
Moon C; Chae YK; Lee J
Exp Biol Med (Maywood); 2010 Aug; 235(8):907-20. PubMed ID: 20562132
[TBL] [Abstract][Full Text] [Related]
5. Emerging molecular targeted therapies in the treatment of head and neck cancer.
Bozec A; Peyrade F; Fischel JL; Milano G
Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
[TBL] [Abstract][Full Text] [Related]
6. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
Le Tourneau C; Siu LL
Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor directed therapy in head and neck cancer.
Choong NW; Cohen EE
Crit Rev Oncol Hematol; 2006 Jan; 57(1):25-43. PubMed ID: 16207530
[TBL] [Abstract][Full Text] [Related]
8. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
9. New targets for non-small-cell lung cancer therapy.
Alvarez M; Roman E; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial.
Rivera F; García-Castaño A; Vega N; Vega-Villegas ME; Gutiérrez-Sanz L
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1421-8. PubMed ID: 19828002
[TBL] [Abstract][Full Text] [Related]
11. Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer.
Khalil MY; Grandis JR; Shin DM
Expert Rev Anticancer Ther; 2003 Jun; 3(3):367-80. PubMed ID: 12820779
[TBL] [Abstract][Full Text] [Related]
12. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
13. [Combination therapy with molecular targeting drugs for head and neck cancer].
Fujii M
Gan To Kagaku Ryoho; 2008 May; 35(5):740-4. PubMed ID: 18487910
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapy in head and neck cancer.
Licitra L; Bergamini C; Mirabile A; Granata R
Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):132-7. PubMed ID: 21372717
[TBL] [Abstract][Full Text] [Related]
15. A review on the treatment of relapsed/metastatic head and neck cancer.
Ferrari D; Codecà C; Fiore J; Luciani A; Foa P
Expert Opin Pharmacother; 2009 Nov; 10(16):2625-32. PubMed ID: 19708856
[TBL] [Abstract][Full Text] [Related]
16. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
Gilbert J; Argiris A
Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for esophageal cancer.
Homs MY; Voest EE; Siersema PD
Expert Opin Emerg Drugs; 2009 Jun; 14(2):329-39. PubMed ID: 19453287
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
Ang KK; Andratschke NH; Milas L
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):959-65. PubMed ID: 14967456
[TBL] [Abstract][Full Text] [Related]
19. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.
Astsaturov I; Cohen RB; Harari P
Expert Rev Anticancer Ther; 2006 Sep; 6(9):1179-93. PubMed ID: 17020453
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of cetuximab in head and neck cancer: a 2007 perspective.
Panikkar RP; Astsaturov I; Langer CJ
Cancer Invest; 2008 Feb; 26(1):96-103. PubMed ID: 18181051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]